In This Section

CICR Steering Committee

Mary M. Mader, PhD
Chair

Mary M. Mader, PhD

(2022-2024)

Vice-President
Molecular Innovation
Indiana Biosciences Research Institute
Indianapolis, Indiana

Joachim Rudolph, PhD
Past Chair

Joachim Rudolph, PhD

(2022-2023)

Principal Scientist
Discovery Chemistry
Genentech, Inc.
South San Francisco, California

Rima Al-awar, PhD

Rima Al-awar, PhD

(2021-2024)

Head, Therapeutic Innovation and Drug Discovery
Ontario Institute for Cancer Research
Toronto, Canada

Michelle Arkin, PhD

Michelle Arkin, PhD

(2021-2024)

Professor, Pharmaceutical Chemistry, School of Pharmacy
University of California San Francisco
San Francisco, California 

Sara Buhrlage, PhD

Sara Buhrlage, PhD

(2022-2025)

Associate Professor
Cancer Biology, Dana-Farber Cancer Institute
Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Boston, Massachusetts

Danette L. Daniels, PhD

Danette L. Daniels, PhD

(2022-2025)

Vice-President
Protein Degrader Platform
Foghorn Therapeutics
Cambridge, Massachusetts

Laura D’Agostino, PhD

Laura D’Agostino, PhD

(2020-2023)

Director
Bristol Myers Squibb
Cambridge, Massachusetts

Benjamin L. Ebert, PhD

Benjamin L. Ebert, PhD

(2021-2024)

George P. Canellos, MD, and Jean S. Canellos Professor of Medicine
Harvard Medical School;
Chair of Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

Adrian L. Gill, PhD

Adrian L. Gill, PhD

(2020-2023)

Vice President, Medicinal Chemistry
Revolution Medicines
Redwood City, California

Ingo Hartung, PhD

Ingo Hartung, PhD

(2021-2024)

Director and Head of Medicinal Chemistry GER
Merck Healthcare KGaA
Darmstadt, Germany

David Millan, PhD

David Millan, PhD

(2021-2024)

Vice President, Head of Chemistry
Foghorn Therapeutics
Cambridge, Massachusetts 

Christopher Nasveschuk, PhD

Christopher Nasveschuk, PhD

(2020-2023)

Vice President, Chemistry
C4 Therapeutics
Watertown, Massachusetts

Daniel K. Nomura, PhD

Daniel K. Nomura, PhD

(2022-2025)

Professor of Chemical Biology
Department of Chemistry
University of California, Berkeley

Jennifer C. Petter, PhD

Jennifer C. Petter, PhD

(2022-2025)

Founder and Chief Innovation Officer
Arrakis Therapeutics
Waltham, Massachusetts

Zoran Rankovic, PhD

Zoran Rankovic, PhD

(2020-2023)

Director, CBT Chemistry Centers
St. Jude Children’s Research Hospital
Memphis, Tennessee

Hong Shen, PhD

Hong Shen, PhD

(2022-2025)

Head of Roche Innovation Center Shanghai (RICS)Head of Therapeutic Modalities and Technologies at RICS
Shanghai, China